Document Detail

Stereotactic radiosurgery in elderly patients with brain metastases.
MedLine Citation:
PMID:  23187817     Owner:  NLM     Status:  Publisher    
Stereotactic radiosurgery (SRS) has been increasingly employed as an alternative to whole brain radiation therapy in patients with brain metastases, with the aim to reduce its potential toxicity. We have evaluated clinical outcomes of SRS as initial treatment for brain metastases in patients 70 years and older. Between November 2007 and October 2011, 102 patients of 70 years and older with 1-4 metastases were treated with SRS. The primary end point of the study was overall survival. Secondary end points were local control and distant failure rates, cause of death, performance measurements, and toxicity of treatment. At a median follow-up of 11.0 months (range 1-48 months), median survival and median time to distant failure were 13.2 and 10 months, respectively. The 1- and 2-year survival rates were 63 and 28 %, and respective distant failure rates were 54 and 78 %. Forty-five patients succumbed to their extracranial disease and 14 patients died of progressive intracranial disease. Nine patients recurred locally after SRS. The 1- and 2-year local control rates were 90 and 84 %, respectively. Evaluation of neurocognitive function using the Mini-Mental State Examination (MMSE) showed no significant neurocognitive decline after SRS. MMSE score improved in 15 % of patients, worsened in 12 % of patients, and remained stable in the others. Severe neurological complications were reported in 7 (7 %) patients, requiring surgery or medical treatment. Initial treatment with SRS with close monitoring may represent a relatively safe treatment strategy associated with survival benefit, with outcomes similar to those reported in historical series of SRS for younger patients.
Giuseppe Minniti; Vincenzo Esposito; Enrico Clarke; Claudia Scaringi; Alessandro Bozzao; Gaetano Lanzetta; Vitaliana De Sanctis; Maurizio Valeriani; Mattia Osti; Riccardo Maurizi Enrici
Related Documents :
23676537 - Outcome of radical prostatectomy in patients meeting criteria for active surveillance.
23138117 - Outcome of modified st jude total therapy 13a for childhood acute lymphoblastic leukemi...
8342567 - Hemolytic uremic syndrome developing during remission of acute myelomonocytic leukemia.
24574357 - Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-ba...
16172307 - Analysis of t-cell receptor gene rearrangement for predicting clinical outcome in patie...
1828187 - Gastrointestinal toxicity of 5-fu and 5-fudr: radiographic findings.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-28
Journal Detail:
Title:  Journal of neuro-oncology     Volume:  -     ISSN:  1573-7373     ISO Abbreviation:  J. Neurooncol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8309335     Medline TA:  J Neurooncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Unit of Radiation Oncology, Sant' Andrea Hospital, University Sapienza, Via di Grottarossa 1035, 00189, Rome, Italy,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A facile synthesis of iron functionalized hierarchically porous ZSM-5 and its visible-light photocat...
Next Document:  Computer-aided analysis of orbital volume: a novel technique.